Restrictive cardiomyopathy in nurse practice

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Cardiomyopathy (CMP) is a group of heterogeneous diseases characterized by structural or functional changes in the myocardium, not caused by coronary heart disease, hypertension, valvular diseases and congenital diseases. This article deals with problems of etiology, pathogenesis, clinical symptomatology, approaches to detection and treatment of restrictive cardiomyopathy.

Full Text

Restricted Access

About the authors

Vsevolod V. Skvortsov

Federal State Budgetary Educational Institution of Higher Education “Volgograd state medical university” of the ministry of health of the Russian Federation

Author for correspondence.
Email: vskvortsov1@ya.ru
ORCID iD: 0000-0002-2164-3537

Doctor of Medicine, Associate Professor of the Department of Internal Medicine

Russian Federation, Volgograd

Elena V. Belyakova

Federal State Budgetary Educational Institution of Higher Education “Volgograd state medical university” of the ministry of health of the Russian Federation

Email: kursheva.elena.volg@rambler.ru

Candidate of Medical Sciences, Associate Professor of the Department of Internal Medicine

Russian Federation, Volgograd

Andrey Andreevich Eremenko

Federal State Budgetary Educational Institution of Higher Education “Volgograd state medical university” of the ministry of health of the Russian Federation

Email: reak.froman@mail.ru
ORCID iD: 0000-0001-8361-9922

clinical resident

Russian Federation, Volgograd

Natalia V. Eremenko

Federal State Budgetary Educational Institution of Higher Education “Volgograd state medical university” of the ministry of health of the Russian Federation

Email: missis.yasko@mail.ru
ORCID iD: 0000-0003-2596-7958

clinical resident

Russian Federation, Volgograd

References

  1. Blagova O.V., Nedostup A.V. Classification of non-coronary heart diseases: our view of the problem. Russian Cardiology Journal, 2017; 2 (142): 7‒21.
  2. Blagova O.V., Nedostup A.V., Sedov V.P. Clinical masks of amyloidosis with heart lesions: features of diagnostics at the present stage. Russian cardiologic journal, 2017; 2 (142): 68‒79.
  3. Braunwald’s Diseases of the Heart, edited by P. Libby. Volume 4. Moscow, Logosphere, 2015; 1976‒1986.
  4. Kumar V. Fundamentals of disease pathology according to Robbins and Cottran. Moscow, Logosphere; 2016: 655‒660.
  5. Leontieva I.V., Nikolaeva E.A. Cardiomyopathies in congenital metabolic disorders in children. Russian gestnik perinatologii i pediatria, 2, 2016.
  6. Lilly L. Pathophysiology of the cardiovascular system. Binom. Laboratory of Knowledge, 2016. 383‒396; 526.
  7. Frolov V.A. Non-coronagenic myocardial diseases. Study guide. Practical Medicine; 2016: 23‒31.
  8. Seguela PE, et al. Eosinophilic cardiac disease: molecular, clinical and imaging aspects. Arch. cardiovascular disease. 2015; 108 (4): 258–268.
  9. Gregory Ho., Ed Peng et al. Restictive cardiomyopathy or constrictive pericarditis: an unresolved conundrum. World Journal for Pediatric and Congenital Heart Surgery, 2017; 9: 360–363.
  10. Jay Brieler, Matthew A. Breeden. Cardiomyopathy: an overview. American Family Physician, 2017; 96 (10): 640–646.
  11. F. Rodriguez-Mora, A. Adsuar-Gomez. Short-term Use of Ventricular Assist Device in a Patient with Restrictive Cardiomyopathy: A Case Report. Transplantation Proceedings, 2018; 50 (I. 2): 653–654.
  12. Zhang Y, MacCosham A. Mind the Gap: Genetic Variation and Personalized Therapies for Cardiomyopathies. Lifestyle Genom. 2018; (19): 1–3.
  13. Anderson H.N, Cetta F., Driscoll D.J., Olson T.M. Idiopathic Restrictive Cardiomyopathy in Children and Young Adults. The American Journal of Cardiology, 121 (10): 1266–1270.
  14. Marec J. et al. Comparison of echocardiographic parameters in Fabry cardiomyopathy and light-chain cardiac amyloidosis. Echocardiography. 2018; 35 (11): 1755–1763.
  15. Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature and typing. Cardiovascular Pathology. 2015; 24 (6): 343–350.
  16. Sperry BW, Tang WHW. Amyloid heart disease: genetics translated into disease-modifying therapy. Heart, 2017; 103 (11): 812–817.
  17. Hong JA, et al. Clinical features of Idiopathic Restrictive Cardiomyopathy: A retrospective multicenter cohort study over 2 decades. Medicine (Baltimore). 2017; 96 (36): 7886.
  18. Muchtar E. et al. Restrictive Cardiomyopathy: Genetics Pathogenesis, Clinical Manifestations, Diagnosis and Therapy. Circulation Research, 2017; (121): 819–837.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Russkiy Vrach Publishing House